SLFN11 and prostate cancer: A weaker negative correlation between CD47 mRNA expression and SLFN11 promoter methylation (p = 4.6 × 10−19) suggested that the regulation of SLFN11 expression in human prostate cancers by CD47 is mediated in part by this mechanism (Figure 9C).